Interesting, but the details and specific stats re the ovarian cancer survival data wasn't provided in the release. Was stat significant, but no specifics. The underlying drug (Avastin) is a huge selling drug but it
is not approved yet for Ovarian cancer treatment here in the US. Think they're using it in Europe though.
I'm watching it, but not enough confidence in the data that was released today to buy it...just yet.